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Purpose: To compare postoperative outcomes and assess factors associated with intraocular pressure
(IOP) reduction after phacotrabeculectomy in patients with primary open-angle glaucoma (POAG) and
primary angle-closure glaucoma (PACG).
Methods: This is a retrospective study of patients who underwent phacotrabeculectomy between 2010
and 2013. Factors including age, gender, visual ﬁeld (VF), the number of glaucoma medications used,
biometric changes, IOP, and surgical success rates were compared between groups.
Results: There were 27 PACG and 34 POAG patients. The PACG group had a greater mean IOP reduction
after phacotrabeculectomy compared to the POAG group (5.5 ± 7.9 mmHg versus 2.0 ± 4.2 mmHg;
p ¼ 0.03). However, the ﬁnal mean IOP was similar between the two groups (PACG: 12.2 ± 4.8 mmHg,
POAG: 12.3 ± 3.1 mmHg; p ¼ 0.92). Phacotrabeculectomy resulted in a mean decrease in axial length (AL)
of 0.16 ± 0.15 mm in PACG and 0.16 ± 0.11 mm in POAG (p ¼ 0.96), and an increase in anterior chamber
depth (ACD) of 1.41 ± 0.91 mm in PACG, and 0.87 ± 0.86 mm in POAG (p ¼ 0.04). At 2 years follow-up, the
cumulative success rate of phacotrabeculectomy was 74% in PACG and 62% in POAG. Multivariate analysis
found that early glaucoma stage, greater postoperative increase in ACD, and high preoperative IOP were
factors associated with greater IOP reduction.
Conclusion: Postoperative success rates and mean IOP on the ﬁnal visit after phacotrabeculectomy were
similar between the PACG and POAG groups. Factors associated with IOP reduction were greater post-
operative increase in ACD, and high preoperative IOP.
Copyright © 2015, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Glaucoma and cataract incidence increases with age1,2; thus, it is
not uncommon in a clinical setting to encounter a glaucoma patient
with a coexisting visually disabling cataract. Special considerations
are needed when choosing which surgical strategy to undertake
when either of these two conditions requires surgical management.
Whenperformedprior to cataract surgery, trabeculectomy increases
the risk of cataract formation by up to 78%,3 while subsequenthors declare any conﬂicts of
logy, Kaohsiung Chang Gung
District, Kaohsiung City 833,
g).
ciety of Taiwan. Published by Elsecataract surgery may increase the risk of elevated intraocular pres-
sure (IOP) or trabeculectomy failure.4e6 By contrast, when cataract
surgery alone is performed in glaucoma patients, an early post-
operative IOP spike sometimes requiring medical treatment is
commonly reported.7 Therefore, phacotrabeculectomy, a procedure
that combines the management of these two conditions together in
one surgery, may be considered in these situations. Previous studies
have shown that phacotrabeculectomy can provide an IOP-lowering
effect that is not inferior to that of trabeculectomy alone,8,9 and
visual and refractive outcomes following this procedure are com-
parable to those obtained with phacoemulsiﬁcation alone.10,11
However, in the current literature, studies that directly compare
the surgical outcomes of phacotrabeculectomy between patients
with primary open-angle glaucoma (POAG) and primary angle-
closure glaucoma (PACG) are limited.12,13 Furthermore, in the fewvier Taiwan LLC. All rights reserved.
Table 1
Baseline demographic characteristics of the primary open-angle glaucoma (POAG)
and primary angle-closure glaucoma (PACG) groups.
POAG group PACG group p
No. of eyes 34 27
Age (y) 69.0 ± 6.4 71.9 ± 7.2 0.10
Sex (male:female) 16:18 10:17 0.28
Visual ﬁeld mean deviation (dB) 14.08 ± 8.46 13.52 ± 8.88 0.81
No. of preoperative glaucoma
medications
2.2 ± 1.4 2.8 ± 1.5 0.09
Preoperative IOP (mmHg) 14.3 ± 4.7 17.7 ± 7.4 0.04
Preoperative AL 24.91 ± 1.97 22.55 ± 0.66 < 0.001
Preoperative ACD 3.17 ± 0.42 2.46 ± 0.23 < 0.001
Follow-up duration (mo) 17.2 ± 9.7 20.4 ± 10.1 0.65
Data are presented as mean ± SD, unless otherwise indicated.
ACD ¼ anterior chamber depth; AL ¼ axial length; IOP ¼ intraocular pressure;
PACG ¼ primary angle-closure glaucoma; POAG ¼ primary open-angle glaucoma.
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changes and changes in ocular dimensions after surgery have not
been clearly demonstrated. Therefore, the purpose of this study is
to compare postoperative outcomes and to assess factors associated
with IOP reduction after phacotrabeculectomy in POAG and PACG.
2. Materials and methods
2.1. Patient selection
This study was carried out in accordance with the tenets of the
Declaration of Helsinki, and was approved by the Research Ethics
Board of Chang Gung Memorial Hospital, Kaohsiung, Taiwan. The
medical records of patients who underwent one-site phaco-
trabeculectomy with mitomycin-C (MMC) at Kaohsiung Chang
Gung Memorial Hospital from October 2010 to September 2013
were retrospectively reviewed. Indications for surgery were visu-
ally signiﬁcant cataract formation in patients with suboptimal IOP
control under maximal medication, or poor tolerance for glaucoma
medications. All surgeries were performed by one experienced
glaucoma surgeon (M.C.T.).
All of the patients underwent a comprehensive ophthalmic
evaluation that included Goldman applanation tonometry, gonio-
scopy, and stereoscopic examination of the optic disc with a 90
Diopter lens (Volk Optical Inc., Mentor, OH, USA). Patients were
divided into two groups according to the type of glaucoma (PACG
versus POAG). PACG was diagnosed based on the symptoms of
elevated IOP, in the presence of occludable angles or angle synechia
on gonioscopy. Symptoms of elevated IOP included: (1) an episode
of acute angle closure; and (2) intermittent blurred vision, halo, or
ocular pain. All of the PACG patients received laser iridotomy after
diagnosis. POAGwas diagnosed in the presence of open angles with
Shaffer grading > 2 on gonioscopy, and characteristic glaucomatous
optic disc changes with correlating visual ﬁeld (VF) changes. Pa-
tients were excluded if they had any prior intraocular surgery, eye
trauma, or a diagnosis of secondary glaucoma. Additional exclusion
criteria included a follow-up time of < 3 months and incomplete
chart recording. Baseline demographic data were obtained for each
patient, including age, gender, type of glaucoma, VF evaluation
using the Humphrey Field Analyzer (30-2 program, Carl Zeiss
Meditec, Inc., Dublin, CA, USA) performed within 6 months prior to
surgery, and the number of glaucoma medications used. Biometric
measurements, including axial length (AL) and anterior chamber
depth (ACD), were obtained using the IOLMaster (Carl Zeiss Medi-
tec, Inc.) prior to the operation and > 3months after operation. IOPs
were obtained prior to the operation, at postoperative Day 1, and at
1 month, 3 months, 6 months, 9 months, 12 months, 15 months, 18
months, 21 months, and 24 months after the operation. Preopera-
tive IOP was deﬁned as the average IOP of three consecutive ofﬁce
visits prior to the surgery. Total IOP reduction was deﬁned as the
IOP difference between preoperative IOP and IOP on the last visit.
Surgical success was deﬁned as IOP 15 mmHg without the need
for additional glaucoma medication or surgical intervention to
control IOP.
2.2. Surgical methods
Under peribulbar anesthesia, a superior rectus traction suture
was placed and a fornix-based conjunctival ﬂap was created. After
the conjunctiva and Tenon's capsule were dissected, a sponge
soaked with MMC 0.2 mg/mL was placed in the conjunctival pocket
between the conjunctiva and episclera for 2 minutes, after which
the conjunctival space was irrigated with copious amounts of
balanced salt solution. Next, a 2 mm  4 mm partial thickness
scleral ﬂap was created with a crescent knife, and the anteriorchamber was entered at the base of the scleral ﬂap using a 2.75 mm
keratome. Phacoemulsiﬁcation was performed using the divide-
and-conquer technique, and a foldable acrylic intraocular lens
was placed in the capsular bag. Next, a sclerotomywas created with
a scleral punch, followed by a peripheral iridectomy. The scleral ﬂap
was loosely closed with one or two interrupted 10-0 nylon sutures,
depending on the amount of leakage underneath the scleral ﬂap.
The conjunctiva was closed using a running 10-0 nylon suture.
Postoperatively, all patients were treated with topical corticoste-
roids and antibiotics four times daily, which was gradually tapered
over a 4-week course.
2.3. Statistical analysis
Statistical analyses were performed using SPSS software version
17.0 (IBM Corp., Armonk, NY, USA). Differences between the two
groups were evaluated with the Student t test for continuous vari-
ables, and with the c2 test for categorical variables. Kaplan-Meier
analysis was used to analyze the cumulative success rate after sur-
gery in the POAG and PACG groups, and differences in success rates
were assessed using the log-rank test. Independent variables rele-
vant to IOP reduction and operation success were identiﬁed using
multivariate analysis by linear regression and binary logistic
regression, respectively. A p value<0.05was considered statistically
signiﬁcant. All data are expressed as mean ± standard deviation.
3. Results
A total of 61 eyes of 51 patients (mean age, 70.3 ± 6.8 years;
range, 59e87 years) with a mean follow-up time of 19.1 ± 9.9
months (range, 3e40 months) were included in this analysis.
Twenty-seven eyes in the PACG group were compared to 34 eyes in
the POAG group (Table 1).
The mean preoperative IOP was 17.7 ± 7.4 mmHg in the PACG
group and 14.3 ± 4.7 mmHg in the POAG group (p ¼ 0.04). IOP
throughout the follow-up period after surgery was not statistically
different between the two groups (Fig.1). At the ﬁnal follow-up, the
mean IOPwas similar between the PACG (12.2± 4.8mmHg) and the
POAG (12.3 ± 3.1 mmHg) groups (p ¼ 0.92). However, the PACG
group had a signiﬁcantly greater mean total IOP reduction after
phacotrabeculectomy compared to the POAG group (5.5 ±
7.9 mmHg versus 2.0 ± 4.2 mmHg; p ¼ 0.03).
Phacotrabeculectomy resulted in a decrease in AL from
24.91 ± 1.97 mm to 24.64 ± 1.50 mm in the POAG group, and from
22.55 ± 0.66 mm to 22.47 ± 0.67 mm in the PACG group. There was
also an increase in ACD from 3.17 ± 0.42 mm to 3.94 ± 0.54 mm in
the POAG group, and from 2.46 ± 0.23mm to 3.66 ± 0.53 mm in the
PACG group. The total change in AL was similar between the two
Fig. 1. Intraocular pressure proﬁles in the primary angle-closure glaucoma (PACG) and
the primary open-angle glaucoma (POAG) groups.
Table 3
Comparison of postoperative interventions.
Number of patients (%)
POAG group PACG group
Numbers of medications used
0 24 (70) 21 (78)
1 2 (6) 3 (11)
2 3 (9) 2 (7)
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group and0.16 ± 0.11 mm in the POAG group (p¼ 0.96). However,
in the PACG group, the increase in ACD after surgery was signiﬁ-
cantly greater than in the POAG group (1.41 ± 0.91 mm versus
0.87 ± 0.86 mm, respectively; p ¼ 0.04; Table 2).
Kaplan-Meier survival analysis (Fig. 2) shows that most of the
surgical failures occurred in the ﬁrst 3e6 months in the PACG
group, while in the POAG group, most of the surgical failures
occurredwithin 1 year. At 2 years follow-up, the cumulative success
rate of those that qualiﬁed for complete surgical success was 74% inTable 2
Changes in ocular dimensions in primary open-angle glaucoma (POAG) and primary
angle-closure glaucoma (PACG).
POAG group PACG group p
Total change in axial length (mm) 0.16 ± 0.11 0.16 ± 0.15 0.96
Total change in ACD (mm) 0.87 ± 0.86 1.41 ± 0.91 0.04
Data are presented as mean ± SD.
ACD ¼ anterior chamber depth.
Fig. 2. Kaplan-Meier cumulative probability curve for complete success after phaco-
trabeculectomy, as deﬁned by intraocular pressure < 15 mmHg without any additional
medications or surgery, in primary angle-closure glaucoma and primary open-angle
glaucoma.the PACG group and 62% in the POAG group, which was not sig-
niﬁcant (log-rank test; p ¼ 0.90). The number of glaucoma medi-
cations used decreased from 2.8 ± 1.5 medications to 0.31 ± 0.17
medications (p < 0.001) in the PACG group, and from 2.2 ± 1.4
medications to 0.74 ± 0.22 medications (p < 0.001) in the POAG
group. The number of patients that remained medication-free
(with or without further bleb revision) throughout the follow-up
period after the operation for the PACG group and the POAG
group was similar, at 78% and 70%, respectively (Table 3).
Multivariate analysis showed that a greater ACD change (b
coefﬁcient ¼ 0.248, p ¼ 0.03), higher baseline IOP (b
coefﬁcient ¼ 1.611, p < 0.001), and a lower mean deviation on VF (b
coefﬁcient¼0.297, p¼ 0.05) were independent factors associated
with greater IOP reduction after phacotrabeculectomy (Table 4).
Older age (odds ratio: 1.052, p ¼ 0.02) and fewer preoperative
medications (odds ratio: 0.501, p ¼ 0.04) were factors associated
with surgical success (Table 5).4. Discussion
Due to the advantage of being able to treat coexisting cataracts
and glaucoma in one surgery, phacotrabeculectomy has gained
popularity among ophthalmic surgeons over the past decade.8,12e163 3 (9) 0 (0)
4 2 (6) 1 (4)
Surgical intervention
Needle revision 4 (12) 5 (19)
PACG ¼ primary angle-closure glaucoma; POAG ¼ primary open-angle glaucoma.
Table 4
Multivariate analysis of factor associated with a greater postoperative intraocular
pressure (IOP) reduction.
Beta coefﬁcient p 95% CI
Sex (male) 0.148 0.12 0.374e3.174
Age 0.007 0.95 0.105e0.111
Visual ﬁeld mean deviation 0.297 0.05 0.261e0.002
Type of glaucoma (POAG) 0.183 0.07 3.738e0.1333
Preoperative baseline IOP 1.611 < 0.001 0.506e0.843
Total ACD change 0.248 0.03 0.104e2.395
Total AL change 0.034 0.78 5.748e8.146
ACD ¼ anterior chamber depth; AL ¼ axial length; CI ¼ conﬁdence interval;
IOP ¼ intraocular pressure; POAG ¼ primary open-angle glaucoma.
Table 5
Multivariate analysis of factors associated with surgical success. Surgical success was
deﬁned as intraocular pressure (IOP)  15 mmHg without the need for additional
glaucoma medication or surgical intervention to control IOP.
p Odds ratio 95% CI
Sex (male) 0.76 1.267 0.279e5.747
Age 0.02 1.052 1.009e1.098
Type of glaucoma (POAG) 0.51 0.602 0.135e2.682
Visual ﬁeld mean deviation 0.783 1.014 0.919e1.119
Number of preoperative medications 0.04 0.501 0.258e0.973
Preoperative IOP 0.91 1.007 0.889e1.140
CI ¼ conﬁdence interval; IOP ¼ intraocular pressure; POAG ¼ primary open-angle
glaucoma.
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visual acuity17 and the increased incidence of cataract formation
after surgery,3 which can be overcome in combined cataract
extraction and glaucoma surgery. Furthermore, despite being a
more complex surgery, phacotrabeculectomy has been shown to
achieve a favorable visual and refractive outcome that is compa-
rable to phacoemulsiﬁcation alone.10,11 Moreover, even though
trabeculectomy has traditionally been considered the gold standard
for surgical control of IOP in glaucoma patients, with improvements
and advances in surgical techniques, such as the use of intra-
operative adjuvant MMC in the conjunctival pocket, fornix-based
conjunctival ﬂap, two-site procedure using temporal wound for
cataract extraction,15,16 IOP can be effectively lowered after surgery.
In a retrospective study comparing trabeculectomy with MMC and
phacotrabeculectomy with MMC, Murthy et al8 found that there
was no difference in postoperative IOP between the two groups for
up to 2 years. Similarly, Tsai et al9 found that at 3 years post-
operatively in a group of PACG patients, the surgical success rate
was similar (p ¼ 0.903) between trabeculectomy (54%) and pha-
cotrabeculectomy (56%), with no signiﬁcant IOP differences
throughout the follow-up period.
Consistent with the previous comparative studies,12,13 we found a
greater IOP reduction after phacotrabeculectomy in the PACG group.
In a study by Lai et al,12 the PACG group had a mean IOP reduction of
12.7 ± 8.3 mmHg, whereas the POAG group showed a mean IOP
reduction of 5.0 ± 5.7 mmHg (p < 0.05). Rao et al13 reported a mean
IOP reduction of 8.1 ± 8.4 mmHg in PACG and 5.5 ± 7.3 mmHg in
POAG (p ¼ 0.03) after phacotrabeculectomy without MMC. In our
study, themean IOP reductionwas not as great as that reported in the
previous studies; however, this may be explained by the relatively
higher preoperative baseline IOP in their patients (Lai et al12:
27.4mmHg inPACGand20.4mmHg inPOAG;Rao et al13: 23.0mmHg
in PACG and 20.3 mmHg in POAG) compared to our patients (17.7 ±
7.4 mmHg in PACG and 14.3 ± 4.7 mmHg in POAG).
In addition, our study is different from the previous studies
because in the study by Lai et al,12 MMC was used mostly in PACG
patients and only selectively used among POAG patients, whereas
in the study by Rao et al,13 MMC was not applied at all. MMC is an
important adjunct to glaucoma ﬁltration surgery because of its
wound-modulating and antiﬁbrotic properties.18 In a systematic
review that included four randomized clinical trials and two cohort
studies investigating the effects of MMC on IOP, Jampel et al16
concluded that IOP reduction was greater in cases that used MMC
in combined cataract and glaucoma surgery than in those that did
not. In our study, a ﬁxed concentration of 0.2 mg/mL MMC for 2
minutes was used on the scleral surface in all cases. Even though
there is a possibility that the lack or variable use of MMC might
have inﬂuenced the surgical outcomes in the previous studies,12,13
we found that even with the routine use of adjuvant MMC in
both POAG and PACG patients, a greater IOP reduction was
consistently found in the PACG group.
Previous studies have demonstrated that after cataract extrac-
tion, deepening of the anterior chamber and widening of the angle
occurs in PACG patients.19,20 In a study by Hayashi et al,19 cataract
extraction resulted in a mean increase of 2.08 ± 0.39 mm in ACD,
and 17.8 widening in the angle width in PACG patients 12 months
after surgery. Lai et al20 found that phacoemulsiﬁcation resulted in
a decrease in the extent of synechial closure of the angle to < 90 in
33.3% of their PACG patients. Both of these studies showed that the
anatomic changes led to a reduced IOP and decreased the need for
glaucomamedications in glaucoma patients.19,20 To our knowledge,
there have been no studies that directly assessed the role of AL and
ACD changes in IOP reduction after phacotrabeculectomy.
In our study, the PACG group had an ACD that was signiﬁcantly
shallower than the POAG group prior to surgery. However, aftersurgery, the mean ACD in the PACG group increased to a depth
similar to the POAG group (3.66 ± 0.53 mm and 3.94 ± 0.54 mm,
respectively, p ¼ 0.08), leading to a greater total change in ACD in
the PACG group (PACG: 1.41 ± 0.91mm, and POAG: 0.87 ± 0.86mm;
p ¼ 0.04). The PACG group also had a greater total IOP reduction
after phacotrabeculectomy compared to the POAG group
(5.5 ± 7.9 mmHg versus 2.0 ± 4.2 mmHg; p ¼ 0.03). Even though in
our study the PACG group had a higher baseline IOP than the POAG
group (17.7 ± 7.4 mmHg and 14.3 ± 4.7 mmHg, respectively,
p ¼ 0.04), which may have contributed to a greater IOP reduction
after surgery, multivariate analysis showed that both the total ACD
change and preoperative baseline IOP were independent factors
associated with IOP reduction. Thus, the greater increase in ACD
after phacotrabeculectomy has a deﬁnite role in the greater IOP
reduction we observed in the PACG group.
Following glaucoma ﬁltration surgery, most cases showed a
shortened AL,21,22 which has been associated with younger age,
myopia, exposure to antimetabolites, IOP drop > 30 mmHg,21 and
choroidal thickening.22 A postoperative decrease in AL was also
found in this study, but the change was small in both groups, and it
was not associated with IOP reduction.
With a mean follow-up period of 19.9 months, the surgical
success rate of phacotrabeculectomy at 2 years was 74% in the PACG
group and 62% in the POAG (p ¼ 0.90). We found that older age and
fewer preoperative medications were factors associated with sur-
gical success. In a cohort of 120 patients, Rao et al13 found that
younger age at surgery was signiﬁcantly associated with surgical
failure. Other reported prognostic indicators for surgical failure
after combined glaucoma and cataract extraction surgery include a
glaucoma diagnosis other than primary glaucoma,23 diabetes
mellitus, African-American race, > 2 preoperative glaucoma med-
ications, and having a preoperative IOP of > 20 mmHg.24
This study's main limitations are its retrospective study design
and the small sample size, which may inﬂuence the validity of the
study results. Selection bias may exist because this was a retro-
spective chart review, and patients with incomplete medical charts
were excluded from this study. However, we intended to minimize
this effect by matching the two groups of patients by age, sex, VF,
numbers of preoperative medications used, and follow-up dura-
tion. Another limitation of this study is that we only assessed
changes in ACD prior to and after surgery and not the actual
anatomic changes in anterior chamber angle width; thus, the status
of the angle can only be assumed based on the ACD. Because most
of our patients lacked a record of postoperative gonioscopic eval-
uation, we did not include changes in angle width as one of the
study outcome parameters. However, since a clear association be-
tween ACD and anterior chamber angle has been well established
in the published literature,25 we feel that we can reliably use the
ACD change to explain the greater IOP reduction observed in the
PACG group.
In conclusion, the results of this study show that phaco-
trabeculectomy with MMC can reduce IOP and the number of
glaucoma medications needed in both PACG and POAG patients.
Postoperative success rates and IOP levels after phaco-
trabeculectomy were similar between the PACG and POAG groups.
Older age and fewer preoperative glaucoma medications were
factors associated with surgical success, and factors associated with
IOP reduction were greater postoperative increase in ACD, and a
high preoperative IOP.
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